Analysis of Yearly Variations in Drug Expenditure for One Patient Using Data Warehouse in a Hospital

Medical expense has grown rapidly in Japan. It could be caused by the increase of the patient number and the increase of medical expense per patient. We studied the latter factor on drug expenditure from 1996 to 2002 using the prescription data stored in the data warehouse of one hospital. We found that the drug expenditure per patient had increased 1.32 times. The mean number of prescriptions per patient increased 1.23 times and the mean expenditure of one medicine increased 1.08 times. These results demonstrated that drug expenditure for one patient had gradually increased. This was caused by both the rise in the number of medicines taken by one patient and the rise in the prices of medicines. The data warehouse in the hospital was useful for the analysis of the trends in medical expenditure for one patient.

[1]  Detection The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) , 1997 .

[2]  A. Chawla,et al.  Explaining drug spending trends: does perception match reality? , 2000, Health affairs.

[3]  L Ruilope Human pharmacokinetic/pharmacodynamic profile of irbesartan: a new potent angiotensin II receptor antagonist. , 1997, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[4]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[5]  Nilay D Shah,et al.  Projecting future drug expenditures--2003. , 2003, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[6]  M Ishii,et al.  [The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, and 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension]. , 2000, Nihon rinsho. Japanese journal of clinical medicine.

[7]  Lippincott Williams Wilkins,et al.  1993 guidelines for the management of mild hypertension. Memorandum from a World Health Organization/International Society of Hypertension meeting. Guidelines Subcommittee of the WHO/ISH Mild Hypertension Liaison Committee. , 1993, Hypertension.

[8]  F M Haaijer-Ruskamp,et al.  The cost of prescription medicines to patients. , 2000, Health policy.

[9]  G. Anderson,et al.  Population aging: a comparison among industrialized countries. , 2000, Health affairs.

[10]  G. Anderson,et al.  Health spending, access, and outcomes: trends in industrialized countries. , 1999, Health affairs.

[11]  Tetsuro Chino,et al.  The present and future National Medical Expenditure in Japan (in Japanese) , 1997 .

[12]  V MONALDI,et al.  [Labor and welfare]. , 1951, Archivio di tisiologia e delle malattie dell'apparato respiratorio.